Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sustained and controlled release preparation and preparation method and preparation of in situ tumor immune combination therapy drug application

A technology of controlled release preparation and immunogenicity, which is applied in the field of biomedical nanomaterials, can solve the problems of increasing drug toxicity and side effects, poor drug targeting, and toxic and side effects, and achieves reduction of toxic side effects, high compliance, and high drug loading capacity. Effect

Active Publication Date: 2022-01-07
HUAZHONG UNIV OF SCI & TECH
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the safety of combination therapy is still the focus of clinical trials, and some combination therapy programs may further increase the toxic side effects of drugs on the body
The traditional infusion route often produces huge toxic and side effects due to poor drug targeting, which makes it difficult for the drug to play a local role in the tumor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sustained and controlled release preparation and preparation method and preparation of in situ tumor immune combination therapy drug application
  • Sustained and controlled release preparation and preparation method and preparation of in situ tumor immune combination therapy drug application
  • Sustained and controlled release preparation and preparation method and preparation of in situ tumor immune combination therapy drug application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Weigh the prescription according to Table 1, put soybean lecithin (SPC100), sorbitan monooleate (SMO), tocopheryl acetate (TA) and absolute ethanol with different mass ratios in 10mL EP tubes (wherein control TA 10 parts by mass), sealed with sealing glue, then placed on a multi-point magnetic stirrer to stir overnight at 1000 rpm / min, and then placed in an ultrasonic instrument to remove bubbles by ultrasonication to obtain a clear and transparent light yellow liquid crystal precursor solution. Remove the needle part of the 1ml syringe, absorb 0.1ml of the liquid crystal precursor, reinstall the needle of the syringe, inject the liquid crystal precursor into the PBS buffer, check whether it can be injected successfully and observe whether it can form a semi-solid gel and record it. gel time.

[0039] It can be found from Table 1 that with the increase of absolute ethanol, it is easier to form a clear and transparent liquid crystal precursor, and the fluidity is better,...

Embodiment 2

[0043] On the basis of Example 1, we weighed 45 parts by mass of SPC100, 35 parts by mass of SMO, 10 parts by mass of TA and 10 parts by mass of Ethanol to prepare a blank liquid crystal precursor. After the clear and transparent liquid crystal precursor solution was formed, take Part of it was added to a blank ampoule, and the fluidity of the liquid crystal precursor was observed by tilting the ampoule. Then add a certain amount of PBS buffer solution, and tilt the ampoule again after 10 minutes to observe the fluidity of the liquid crystal precursor at the bottom, the results are as follows figure 1 As shown, a semi-solid gel was formed after 10 min. In addition, remove the needle part of the 1ml syringe, absorb 0.1ml of the liquid crystal precursor, reinstall the needle of the syringe, and inject the liquid crystal precursor into the PBS buffer, the results are as follows figure 2 The gel precursors shown form gels immediately upon exposure to aqueous media.

Embodiment 3

[0045] Separately weigh 45 parts by mass of SPC100, 45 parts by mass of GDO, and 10 parts by mass of ethanol in a 10mL EP tube, seal it with sealing glue, and then place it on a multi-point magnetic stirrer to stir overnight at 1000rpm / min, and then place it in an ultrasonic instrument to sonicate Remove the bubbles to clear and transparent light yellow liquid crystal precursor solution. Remove the needle part of the 1ml syringe, absorb 0.1ml of the liquid crystal precursor, reinstall the needle of the syringe and push the liquid crystal precursor into the PBS buffer, the gel precursor will form a gel immediately when it meets water.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a sustained and controlled release preparation, a preparation method and the application of preparing in situ tumor immunotherapy combined therapy, and relates to the technical field of biomedical nanomaterials. The sustained and controlled release preparation uses a liquid crystal gel as a carrier, and the liquid crystal gel is loaded with an immunogenic inducer and an immunomodulator. The sustained and controlled release preparation can be prepared into a liquid crystal precursor by a simple stirring and mixing method, and then loaded with an immunogenic inducer and an immunomodulator. In the present invention, the immunogenic inducer and the immunomodulator are co-loaded in the in-situ slow-release liquid crystal gel, and after intratumoral, peritumoral or postoperative intratumoral administration, a semi-solid gel can be formed in situ, and the sustained-control Release drugs, effectively regulate the tumor microenvironment, play a role in inhibiting tumor growth, recurrence and metastasis, while reducing systemic side effects caused by traditional drug administration routes, and have potential application prospects in in situ local treatment of tumors.

Description

technical field [0001] The invention relates to the technical field of biomedical nanomaterials, in particular to a sustained and controlled release preparation and its preparation method and the application of preparation of in situ tumor immunotherapy combination therapy. Background technique [0002] Cancer has long been one of the diseases threatening global public health, and it is also one of the public problems that seriously threaten the health of the Chinese people. Common cancer treatment methods include chemotherapy, radiotherapy, surgical resection, and immunotherapy, among which surgical resection is currently the most important treatment for solid tumors. However, tumor recurrence and metastasis caused by postoperative residual tumor and circulating tumor cells or immunosuppressive microenvironment are still the main causes of patient death. [0003] Cancer immunotherapy has been shown to be a promising therapeutic approach that activates the host's immune sys...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/06A61K31/704A61K31/337A61K31/555A61K31/7068A61K41/00A61K38/17A61K31/708A61K39/395A61K39/00A61K38/20A61K38/19A61K9/06A61K47/24A61K47/14A61K47/22A61P35/00A61P35/04
CPCA61K45/06A61K31/704A61K31/337A61K31/555A61K31/7068A61K41/0057A61K41/0071A61K41/0052A61K41/0042A61K38/177A61K31/708A61K39/39558A61K39/0011A61K38/2066A61K38/193A61K9/06A61K47/24A61K47/14A61K47/22A61K9/0019A61P35/00A61P35/04A61K2300/00
Inventor 张志平胡梅张娇
Owner HUAZHONG UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com